Cathie Wood's ARK buys Tesla, sells Coinbase in latest trades

On July 15, 2025, Cathie Wood's ARK ETFs executed significant portfolio adjustments, notably increasing its Tesla Inc. stake with a $36.56 million purchase, reflecting a continued accumulation trend. Concurrently, ARK substantially reduced its exposure to Coinbase Global Inc. by divesting $13.48 million in shares, marking a continued scale-back, and also sold $6.11 million in Roku Inc. shares, signaling a potential strategic shift. These key trades provide insight into ARK's evolving sector convictions and portfolio management strategy.

Analysis

Cathie Wood's ARK ETFs executed significant and divergent portfolio adjustments on July 15, 2025, signaling clear shifts in conviction. The firm reinforced its bullish stance on Tesla (TSLA) with a substantial purchase of 115,380 shares valued at $36.56 million, continuing a recent accumulation trend. Conversely, ARK demonstrated waning conviction in the digital asset and streaming media sectors by divesting $13.48 million from Coinbase (COIN) and $6.11 million from Roku (ROKU). The Roku sales are explicitly noted as part of a series, indicating a potential strategic exit. The simultaneous sale of $1.38 million in its own ARK 21Shares Bitcoin ETF (ARKB) further underscores a tactical reduction in crypto-related exposure. In the biotechnology sector, ARK's activity was more nuanced, with a $1.03 million purchase in Caris Life Sciences (CAI) suggesting targeted conviction, while a sale of Guardant Health (GH) for $656,516 points to active portfolio trimming. Smaller trades, including a $492,045 buy of Nvidia (NVDA) and a $452,987 sale of Ansys (ANSS), represent minor tactical adjustments within ARK's broader innovation theme.

Key Decisions for Investors

• Given ARK's continued, large-scale accumulation of Tesla, investors tracking institutional flows may see this as a strong signal of conviction in the electric vehicle maker.
• The persistent selling of Coinbase and Roku by a prominent innovation fund warrants a review of positions in these stocks, as it suggests a potential strategic shift or loss of confidence from a key institutional holder.
• ARK's simultaneous reduction of its holdings in both a crypto exchange (Coinbase) and a spot Bitcoin ETF (ARKB) could be interpreted as a tactical move to decrease overall crypto exposure, advising caution for those aligned with the fund's strategy.
• The divergent trades in the biotech sector, buying Caris Life Sciences while selling Guardant Health, highlight the need for stock-specific due diligence rather than broad sector-based investment theses.